Patterns of tumor oxygenation and their influence on the cellular hypoxic response and hypoxia-directed therapies.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Drug resistance updates

• Publication date

  2006-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.DRUP.2006.07.002PMID 16926105
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activating transcription factor 4.

  2008cited by this paper
• Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer

  2006cited by this paper
• Assessing IRES activity in the HIF-1α and other cellular 5′ UTRs

  2006cited by this paper
• Hypoxia Inhibits Protein Synthesis through a 4E-BP1 and Elongation Factor 2 Kinase Pathway Controlled by mTOR and Uncoupled in Breast Cancer Cells

  2006cited by this paper
• Lysyl oxidase is essential for hypoxia-induced metastasis

  2006cited by this paper
• Gene expression during acute and prolonged hypoxia is regulated by distinct mechanisms of translational control

  2006cited by this paper
• The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha.

  2006cited by this paper
• Assessing IRES activity in the HIF-1alpha and other cellular 5' UTRs.

  2006cited by this paper
• The hypoxia‐inducible‐factor hydroxylases bring fresh air into hypoxia signalling

  2006cited by this paper
• Inhibition of hypoxia inducible factor-1α (HIF-1α) decreases vascular endothelial growth factor (VEGF) secretion and tumor growth in malignant gliomas

  2006cited by this paper
• Mutations in the PI3K/PTEN/TSC2 pathway contribute to mammalian target of rapamycin activity and increased translation under hypoxic conditions.

  2006cited by this paper
• HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption.

  2006cited by this paper
• Direct demonstration of instabilities in oxygen concentrations within the extravascular compartment of an experimental tumor.

  2006cited by this paper
• Gene Expression Programs in Response to Hypoxia: Cell Type Specificity and Prognostic Significance in Human Cancers

  2006cited by this paper
• Hypoxia signalling in cancer and approaches to enforce tumour regression

  2006cited by this paper
• Ribosomal protein S6 phosphorylation: from protein synthesis to cell size.

  2006cited by this paper
• Hypoxia-induced energy stress regulates mRNA translation and cell growth.

  2006cited by this paper
• A selective inhibitor of eIF2alpha dephosphorylation protects cells from ER stress.

  2005cited by this paper
• Perspectives for combination therapy to overcome drug-resistant multiple myeloma.

  2005cited by this paper
• Reduced expression of hypoxia-inducible factor-1alpha in perinecrotic regions of solid tumors.

  2005cited by this paper
• A role for eIF4E and eIF4E-transporter in targeting mRNPs to mammalian processing bodies.

  2005cited by this paper
• Contrasting Properties of Hypoxia-Inducible Factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-Associated Renal Cell Carcinoma

  2005cited by this paper
• Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment.

  2005cited by this paper
• MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies

  2005cited by this paper
• The polypyrimidine tract-binding protein stimulates HIF-1α IRES-mediated translation during hypoxia

  2005cited by this paper
• ER stress‐regulated translation increases tolerance to extreme hypoxia and promotes tumor growth

  2005cited by this paper
• mTOR signaling: implications for cancer and anticancer therapy

  2005cited by this paper
• Echinomycin, a small-molecule inhibitor of hypoxia-inducible factor-1 DNA-binding activity.

  2005cited by this paper
• Carbonic Anhydrase IX Expression and Tumor Oxygenation Status Do Not Correlate at the Microregional Level in Locally Advanced Cancers of the Uterine Cervix

  2005cited by this paper
• The Unfolded Protein Response: A Novel Component of the Hypoxic Stress Response in Tumors

  2005cited by this paper
• Evaluating hypoxia-inducible factor-1alpha as a cancer therapeutic target via inducible RNA interference in vivo.

  2005cited by this paper
• A Selective Inhibitor of eIF2α Dephosphorylation Protects Cells from ER Stress

  2005cited by this paper
• Hypoxic cell turnover in different solid tumor lines.

  2005cited by this paper
• Genetic evidence for a tumor suppressor role of HIF-2alpha.

  2005cited by this paper
• Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study.

  2005cited by this paper
• Induction of interleukin-8 preserves the angiogenic response in HIF-1α–deficient colon cancer cells

  2005cited by this paper
• Activating Transcription Factor 4 Is Translationally Regulated by Hypoxic Stress

  2004cited by this paper
• The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis

  2004cited by this paper
• XBP1 is essential for survival under hypoxic conditions and is required for tumor growth.

  2004cited by this paper
• Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome.

  2004cited by this paper
• XBP1 Is Essential for Survival under Hypoxic Conditions and Is Required for Tumor Growth

  2004cited by this paper
• Translational Repression Mediates Activation of Nuclear Factor Kappa B by Phosphorylated Translation Initiation Factor 2

  2004cited by this paper
• Translation reinitiation at alternative open reading frames regulates gene expression in an integrated stress response

  2004cited by this paper
• Exploiting tumour hypoxia in cancer treatment

  2004cited by this paper
• Survival signalling by Akt and eIF4E in oncogenesis and cancer therapy

  2004cited by this paper
• Tumor-dependent Kinetics of Partial Pressure of Oxygen Fluctuations during Air and Oxygen Breathing

  2004cited by this paper
• Loss of Skeletal Muscle HIF-1α Results in Altered Exercise Endurance

  2004cited by this paper
• Targeting Topoisomerase 1 to inhibit Hypoxia Inducible Factor 1

  2004cited by this paper
• Spontaneous and Controllable Activation of Suicide Gene Expression Driven by the Stress-Inducible Grp78 Promoter Resulting in Eradication of Sizable Human Tumors

  2004cited by this paper
• Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ

  2004cited by this paper
• Targeting hypoxia tolerance in cancer.

  2004cited by this paper
• The LKB1 tumor suppressor negatively regulates mTOR signaling.

  2004cited by this paper
• Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells.

  2004cited by this paper
• Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex.

  2004cited by this paper
• eIF-4E expression and its role in malignancies and metastases

  2004cited by this paper
• Effect on tumor cells of blocking survival response to glucose deprivation.

  2004cited by this paper
• Translational control and metastatic progression: Enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs

  2004cited by this paper
• Radiation activates HIF-1 to regulate vascular radiosensitivity in tumors: role of reoxygenation, free radicals, and stress granules.

  2004cited by this paper
• Hypoxia Selection of Death-resistant Cells

  2004cited by this paper
• Phase II trial of echinomycin in patients with advanced or recurrent colorectal cancer

  2004cited by this paper
• ROS stress in cancer cells and therapeutic implications.

  2004cited by this paper
• Echinomycin: The first bifunctional intercalating agent in clinical trials

  2004cited by this paper
• Differential Roles of Hypoxia-Inducible Factor 1α (HIF-1α) and HIF-2α in Hypoxic Gene Regulation

  2003cited by this paper
• Nrf2 Is a Direct PERK Substrate and Effector of PERK-Dependent Cell Survival

  2003cited by this paper
• Proteasome inhibitors disrupt the unfolded protein response in myeloma cells

  2003cited by this paper
• YC-1: a potential anticancer drug targeting hypoxia-inducible factor 1.

  2003cited by this paper
• The hypoxic response of tumors is dependent on their microenvironment.

  2003cited by this paper
• Tuberous Sclerosis: from Tubers to mTOR

  2003cited by this paper
• 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF.

  2003cited by this paper
• Targeting HIF-1 for cancer therapy

  2003cited by this paper
• Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL

  2003cited by this paper
• An integrated stress response regulates amino acid metabolism and resistance to oxidative stress.

  2003cited by this paper
• Differential roles of hypoxia-inducible factor 1alpha (HIF-1alpha) and HIF-2alpha in hypoxic gene regulation.

  2003cited by this paper
• LKB1, a protein kinase regulating cell proliferation and polarity

  2003cited by this paper
• Hypoxia promotes invasive growth by transcriptional activation of the met protooncogene.

  2003cited by this paper
• The thioredoxin redox inhibitors 1-methylpropyl 2-imidazolyl disulfide and pleurotin inhibit hypoxia-induced factor 1alpha and vascular endothelial growth factor formation.

  2003cited by this paper
• Effect of ascorbate on the activity of hypoxia-inducible factor in cancer cells.

  2003cited by this paper
• BAY-43-9006 Bayer/Onyx.

  2003cited by this paper
• Pharmacodynamic Evaluation of CCI-779, an Inhibitor of mTOR, in Cancer Patients.

  2003cited by this paper
• ATR/ATM Targets Are Phosphorylated by ATR in Response to Hypoxia and ATM in Response to Reoxygenation*

  2003cited by this paper
• FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor.

  2002cited by this paper
• Geldanamycin induces degradation of hypoxia-inducible factor 1alpha protein via the proteosome pathway in prostate cancer cells.

  2002cited by this paper
• Hypoxia-inducible factor-1alpha mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia.

  2002cited by this paper
• Pimonidazole binding and tumor vascularity predict for treatment outcome in head and neck cancer.

  2002cited by this paper
• Regulation of Protein Synthesis by Hypoxia via Activation of the Endoplasmic Reticulum Kinase PERK and Phosphorylation of the Translation Initiation Factor eIF2α

  2002cited by this paper
• Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.

  2002cited by this paper
• Vascular architecture, hypoxia, and proliferation in first-generation xenografts of human head-and-neck squamous cell carcinomas.

  2002cited by this paper
• Hypoxia — a key regulatory factor in tumour growth

  2002cited by this paper
• Transcription Factor HIF-1 Is a Necessary Mediator of the Pasteur Effect in Mammalian Cells

  2001cited by this paper
• Inhibitory PAS domain protein is a negative regulator of hypoxia-inducible gene expression

  2001cited by this paper
• Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix.

  2001cited by this paper
• XBP1 mRNA is induced by ATF6 and spliced by IRE1 in response to ER stress to produce a highly active transcription factor.

  2001cited by this paper
• Clinical Relevance of Intermittent Tumour Blood Flow

  2001cited by this paper
• Feedback Inhibition of the Unfolded Protein Response by GADD34-Mediated Dephosphorylation of eIF2α

  2001cited by this paper
• C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation.

  2001cited by this paper
• Targeting of HIF-α to the von Hippel-Lindau Ubiquitylation Complex by O2-Regulated Prolyl Hydroxylation

  2001cited by this paper
• HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression

  2001cited by this paper
• Induction of glucose-regulated protein 78 by chronic hypoxia in human gastric tumor cells through a protein kinase C-epsilon/ERK/AP-1 signaling cascade.

  2001cited by this paper
• HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O2 Sensing

  2001cited by this paper
• Hypoxic Heterogeneity in Human Tumors: EF5 Binding, Vasculature, Necrosis, and Proliferation

  2001cited by this paper

• Influence of Hypoxia on Tumor Heterogeneity, DNA Repair, and Cancer Therapy: From Molecular Insights to Therapeutic Strategies

  2025cites this paper
• Longitudinal dynamics of the tumor hypoxia response: From enzyme activity to biological phenotype

  2023cites this paper
• Alteration in the expression of the chemotherapy resistance‑related genes in response to chronic and acute hypoxia in pancreatic cancer

  2023cites this paper
• Bio-Responsive Macromolecular Drug and Small-Molecular Drug Conjugates: Nanoparticulate Prodrugs for Tumor Microenvironment Heterogeneity Management and Therapeutic Response Enhancement.

  2023cites this paper
• Understanding ER homeostasis and the UPR to enhance treatment efficacy of acute myeloid leukemia.

  2022cites this paper
• Small extracellular vesicles in cancer

  2021cites this paper
• Hypoxia and cancer related pathology.

  2020cites this paper
• Extracellular Vesicles as Transmitters of Hypoxia Tolerance in Solid Cancers

  2019cites this paper
• Therapeutic Implications of Angiogenesis in Cancer

  2017cites this paper
• Molecular targeting of hypoxia in radiotherapy☆

  2017cites this paper
• Hypoxia increases genome-wide bivalent epigenetic marking by specific gain of H3K27me3

  2016cites this paper
• The timing of surgery after neoadjuvant radiotherapy influences tumor dissemination in a preclinical model

  2015cites this paper
• The unfolded protein response potentiates epithelial-to-mesenchymal transition (EMT) of gastric cancer cells under severe hypoxic conditions

  2014cites this paper
• HIF-1α inhibition blocks the cross talk between multiple myeloma plasma cells and tumor microenvironment.

  2014cites this paper
• Novel bioresponsive drug eluting microspheres to enhance chemoembolisation therapy

  2014cites this paper
• Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography.

  2013cites this paper
• Hypoxia The autophagy associated gene , ULK 1 , promotes tolerance to chronic and acute hypoxia

  2013cites this paper
• New small molecule inhibitors of UPR activation demonstrate that PERK, but not IRE1α signaling is essential for promoting adaptation and survival to hypoxia.

  2013cites this paper
• The relationship between HIF-1α and autophagy activity in the hypoxic environment of breast cancer

  2013influential citation
• The autophagy associated gene, ULK1, promotes tolerance to chronic and acute hypoxia.

  2013cites this paper
• Ecological photodynamic therapy: new trend to disrupt the intricate networks within tumor ecosystem.

  2013cites this paper
• PERK/eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS

  2013cites this paper
• 14-3-3 σ Expression Effects G2/M Response to Oxygen and Correlates with Ovarian Cancer Metastasis

  2011cites this paper
• The ESTRO Breur Lecture 2009. From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer.

  2010cites this paper
• Implementation of hypoxia imaging into treatment planning and delivery.

  2010cites this paper
• Live clostridia : a powerful tool in tumor biotherapy

  2010cites this paper
• Efavirenz Mannich bases: synthesis, anti-HIV and antitubercular activities.

  2009cites this paper
• Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies

  2009cites this paper
• Hypoxia and the Malignant Glioma Microenvironment: Regulation and Implications for Therapy

  2009cites this paper
• Hypoxia-induced Expression of Carbonic Anhydrase 9 Is Dependent on the Unfolded Protein Response*

  2009cites this paper
• [18F]EF3 is not superior to [18F]FMISO for PET-based hypoxia evaluation as measured in a rat rhabdomyosarcoma tumour model

  2009cites this paper
• Mechanisms of proteasome inhibitor action and resistance in cancer.

  2008cites this paper
• Untangling the unfolded protein response

  2008cites this paper
• Hypoxia-induced signaling in the cardiovascular system.

  2008influential citation
• Knocking Down Galectin 1 in Human Hs683 Glioblastoma Cells Impairs Both Angiogenesis and Endoplasmic Reticulum Stress Responses

  2008cites this paper
• Cellular adaptation to hypoxia and reoxygenation through gene specific mRNA translation

  2008cites this paper
• A Dialogue between the Hypoxia-Inducible Factor and the Tumor Microenvironment

  2008cites this paper
• Imaging hypoxia in orthotopic rat liver tumors with iodine 124-labeled iodoazomycin galactopyranoside PET.

  2008cites this paper
• Signaling in the Cardiovascular System

  2008cites this paper
• Hypoxic Reactive Oxygen Species Regulate the Integrated Stress Response and Cell Survival

  2008cites this paper
• The mTOR target 4E‐BP1 contributes to differential protein expression during normoxia and hypoxia through changes in mRNA translation efficiency

  2008cites this paper
• Imaging the hypoxia surrogate marker CA IX requires expression and catalytic activity for binding fluorescent sulfonamide inhibitors.

  2007cites this paper
• Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy.

  2007cites this paper
• Proteomic analysis of gene expression following hypoxia and reoxygenation reveals proteins involved in the recovery from endoplasmic reticulum and oxidative stress.

  2007cites this paper